Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil
Authors:
Open Access
- 1 January 2013
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 36 (1) , 022-027
Abstract
Soroprevalence for Hepatitis C virus is reported as 2.12% in Northern Brazil, with about 50% of the patients exhibiting a sustained virological response (SVR). Aiming to associate polymorphisms in Killer Cell Immunoglobulin-like Receptors (KIR) with chronic hepatitis C and therapy responses we investigated 125 chronic patients and 345 controls. Additionally, 48 ancestry markers were genotyped to control for population stratification. The frequency of the KIR2DL2 and KIR2DL2+HLA-C(Asp80) gene and ligand was higher in chronic infected patients than in controls (p < 0.0009, OR = 3.4; p = 0.001, OR = 3.45). In fact, KIR2DL3 is a weaker inhibitor of NK activity than KIR2DL2, which could explain the association of KIR2DL2 with chronic infection. Moreover, KIR2DS2 and KIR2DS2+HLA-C(Asp80) (p < 0.0001, OR = 2.51; p = 0.0084, OR = 2.62) and KIR2DS3 (p < 0.0001; OR = 2.57) were associated with chronic infection, independently from KIR2DL2. No differences in ancestry composition were observed between control and patients, even with respect to therapy response groups. The allelic profile KIR2DL2/KIR2DS2/KIR2DS3 was associated with the chronic hepatitis C (p < 0.0001; OR = 3). Furthermore, the patients also showed a higher mean number of activating genes and a lower frequency of the homozygous AA profile, which is likely secondary to the association with non-AA and/or activating genes. In addition, the KIR2DS5 allele was associated with SVR (p = 0.0261; OR = 0.184).The ancestry analysis of samples ruled out any effects of population substructuring and did not evidence interethnic differences in therapy response, as suggested in previous studies.Keywords
This publication has 29 references indexed in Scilit:
- Killer‐cell immunoglobulin‐like receptor genotyping and HLA killer‐cell immunoglobulin‐like receptor‐ligand identification by real‐time polymerase chain reactionTissue Antigens, 2011
- Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infectionProceedings of the National Academy of Sciences, 2011
- Allele frequency net: a database and online repository for immune gene frequencies in worldwide populationsNucleic Acids Research, 2010
- Viral hepatitis: Human genes that limit infectionBest Practice & Research Clinical Gastroenterology, 2010
- Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non-respondersLiver International, 2010
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceNature, 2009
- Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral responseBiological Chemistry, 2008
- Hepatitis C Virus (HCV): A Review of Immunological AspectsInternational Reviews of Immunology, 2008
- HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus InfectionScience, 2004
- The Association of Blood Groups, ABH Secretion, Haptoglobins and Hemoglobins with FilariasisHuman Heredity, 1976